Pulse Biosciences, Inc. (PLSE)
| Previous close | 6.86 |
| Open | 6.69 |
| Bid | 6.57 x 200 |
| Ask | 6.73 x 100 |
| Day's range | 6.59 - 6.76 |
| 52-week range | 3.78 - 13.62 |
| Volume | |
| Avg. volume | 164,256 |
| Market cap | 368.347M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.88 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WirePulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024
HAYWARD, Calif., April 24, 2024--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced it will report financial results for the first quarter 2024 after market close on Tuesday, May 7, 2024. Company management will host a corresponding conference call beginning at 1:30pm PT / 4:30pm ET.
Insider MonkeyPulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript
Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2023 Earnings Call Transcript March 28, 2024 Pulse Biosciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Pulse Biosciences Fourth Quarter 2023 Earnings Conference Call. At this time, all […]
- Thomson Reuters StreetEvents
Q4 2023 Pulse Biosciences Inc Earnings Call
Q4 2023 Pulse Biosciences Inc Earnings Call
